» Journals » Curr Med Res Opin

Current Medical Research and Opinion

Current Medical Research and Opinion is a reputable peer-reviewed journal that publishes cutting-edge research in the field of medicine. It covers a wide range of topics including clinical trials, drug development, healthcare policy, and patient care. With its rigorous editorial process, this journal provides valuable insights and evidence-based recommendations for healthcare professionals, researchers, and policymakers to enhance medical practice and improve patient outcomes.

Details
Abbr. Curr Med Res Opin
Publisher Informa Healthcare
Start 1972
End Continuing
Frequency Eight no. a year, 2002-
p-ISSN 0300-7995
e-ISSN 1473-4877
Country United Kingdom
Language English
Metrics
h-index / Ranks: 2214 121
SJR / Ranks: 6179 712
CiteScore / Ranks: 6351 4.20
JIF / Ranks: 4670 2.3
Recent Articles
1.
Tsang C, Zhang X, Ellis A, Zeng J, Wang J
Curr Med Res Opin . 2025 Mar; :1-26. PMID: 40084979
Objective: The Centers for Medicare & Medicaid Services tested the Part D Senior Savings Model ("PDSS Model") in 2021, capping monthly out-of-pocket (OOP) insulin costs at $35. Diabetes disproportionately affects...
2.
Wei C, Chu C, Shen H, Ko P, Chen J, Yu H
Curr Med Res Opin . 2025 Mar; :1-17. PMID: 40079084
Background: Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disorder that significantly impacts renal function. Despite conventional treatments, morbidity and mortality remain high, necessitating the exploration of safer and more...
3.
Yu J, Zhang H, Chen S, Dong D
Curr Med Res Opin . 2025 Mar; :1-7. PMID: 40067752
Background: The long-term treatment of myasthenia gravis (MG) and impaired productivity related to physical decline incur significant economic burdens on affected populations and society. This study aims to evaluate the...
4.
Brenta G, Gottwald-Hostalek U
Curr Med Res Opin . 2025 Mar; :1-9. PMID: 40066580
Hypothyroidism is a relatively common condition that may affect as many as 10% of the population worldwide when its overt and subclinical presentations are considered. Important clinical comorbidities are highly...
5.
Santoro N, Neal-Perry G, Stute P, Blogg M, Mancuso S, Morga A, et al.
Curr Med Res Opin . 2025 Mar; 41(2):375-384. PMID: 40044127
Objective: To assess efficacy and safety of fezolinetant in women unsuitable for hormone therapy (HT), using pooled SKYLIGHT 1 and 2 data. Methods: SKYLIGHT 1 and 2 were double-blind, placebo-controlled...
6.
Lemaire B, Bauer F, Chaves Rodriguez E, Ghesquiere J, Radziejwoski A, Roth A, et al.
Curr Med Res Opin . 2025 Mar; :1-6. PMID: 40040548
Objective: Web resources can contain high-quality data relevant to peer-reviewed medical publications. However, their online location may change or disappear with time. As medical publication professionals, we are concerned with...
7.
Greene M, Gohil S, Camardo M, Ozbay A, Limburg P, Lovelace J
Curr Med Res Opin . 2025 Mar; :1-8. PMID: 40029239
Objective: Colorectal cancer (CRC) poses significant mortality risks, particularly among Black individuals, who experience the highest CRC incidence and mortality rates in the United States. This study examined adherence to...
8.
Feenstra M, Sidenius A, Nielsen C, Kristensen S, Rudnicki M
Curr Med Res Opin . 2025 Mar; 41(2):307-316. PMID: 40025888
Objective: Patient-Reported Outcome (PRO) measures supported by a severity algorithm may serve as a decision aid for triage and consultation in follow-up of patients with endometriosis. In a new follow-up...
9.
Ryll M, Aster I, Zodl A, Thaler S, Rieder C, Tomasi R, et al.
Curr Med Res Opin . 2025 Feb; 41(2):339-346. PMID: 40017339
Objective: Pneumonia continues to be one of the leading causes of death. During the COVID pandemic, pre-existing anticoagulant therapy with direct oral anticoagulants (DOACs) appeared to be beneficial. The present...
10.
Curr Med Res Opin . 2025 Feb; :1. PMID: 40012208
No abstract available.